Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors.
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induced apoptosis specifically in tumor cells. However, with approximately half of all known tumor lines being resistant to TRAIL, the identification of TRAIL sensitizers and their mechanism of action become critical to broadly use TRAI...
Main Authors: | Wanlu Du, Liubov Uslar, Sindhura Sevala, Khalid Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3991662?pdf=render |
Similar Items
-
Choline kinase inhibitors synergize with TRAIL in the treatment of colorectal tumors and overcomes TRAIL resistance
by: Juan Carlos Lacal, et al.
Published: (2016-01-01) -
Overcoming TRAIL Resistance for Glioblastoma Treatment
by: Longfei Deng, et al.
Published: (2021-04-01) -
Overcoming Hypoxic-Resistance of Tumor Cells to TRAIL-Induced Apoptosis through Melatonin
by: You-Jin Lee, et al.
Published: (2014-07-01) -
Resveratrol overcomes TRAIL resistance in human colon cancer cells
by: Xiao-Bing Li, et al.
Published: (2015-07-01) -
Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
by: RACHANA eTRIVEDI, et al.
Published: (2015-04-01)